GE Capital Increases Existing Credit Facility For Saladax Biomedical to $10 Million

 BETHESDA, MD- July 22, 2013 – GE Capital, Healthcare Financial Services, announced today that it has amended its existing $2MM senior secured credit facility to Saladax Biomedical, Inc. to provide an additional $8 million multi-draw term loan facility and to modify the terms of the existing $2 million term loan. GE Capital, Healthcare Financial Services is acting as administrative agent and sole lender for the credit facility. The loans will be used to provide Saladax with working capital to support ongoing commercialization efforts and for other corporate purposes.

 

“GE has been our lender for a number of years, so they know our business well and were able to provide us with additional capital at better terms,” said Kevin Harter, CEO of Saladax. “This loan complements our Series D equity raise and allows us to increase our clinical development and commercialization efforts.”

 

“We are pleased to provide financing that will allow Saladax to invest and grow within the personalized medicine field,” said Anthony Storino, senior managing director, GE Capital, Healthcare Financial Services, Life Sciences. “Providing customized financing to support the unique needs of life sciencesA cluster of scientific disciplines concerned with human life and health. Included are many branches of biology (e.g., molecular biology, cell biology) and chemistry (e.g., biochemistry), as well as some areas of genetics, physics and materials science, among others. companies is our team’s specialty.”

 

About GE Capital, Healthcare Financial Services

With in-depth industry knowledge and expertise, GE Capital, Healthcare Financial Services has provided more than $60 billion in financing over ten years to companies in 45 healthcare sectors including senior housing, hospitals, medical offices, outpatient services, pharmaceuticals and medical devices. Our team of professionals creates business and financial solutions tailored to meet the individual needs of our customers.

 

For more information, visit gecapital.com/healthcare.

GE Capital offers consumers and businesses around the globe an array of financial products and services. For more information, visit www.gecapital.com or follow company news via Twitter (@GECapital). GE (NYSE: GE) works on things that matter. The best people and the best technologies taking on the toughest challenges. Finding solutions in energy, health and home, transportation and finance. For more information, visit the company’s website at www.ge.com.

 

About Saladax Biomedical, Inc.

Saladax Biomedical is a leader in the development and deployment of high quality diagnostic services and products, delivering actionable data to help physicians to select and optimize the use of current and new pharmaceutical products, with the goals of improving health and positively impacting the economics of care. Saladax also serves as a valuable collaborator for pharmaceutical and biotechnology companies in the development of companion diagnostics (CDx), addressing multiple risks and challenges encountered in drug development.

 

Headquartered in Bethlehem, Pennsylvania, Saladax was founded in 2004 and is ISO 13485:2003 certified.

 

Saladax Biomedical, Inc.

Lorraine Damico, MBA

Director of Worldwide Marketing

moc.x1493618868adala1493618868s@oci1493618868madl1493618868

 

GE Capital, Americas Contact

Allison Perkins

203-229-1447

moc.e1493618868g@sni1493618868krep.1493618868nosil1493618868la1493618868

 

  • The Funding Process

    The Funding Process

    The Life Sciences Greenhouse of Central Pennsylvania provides investment funding up to $1 million in milestone-driven convertible…

    Read more
  • Our Resource Center

    tomb2

    It’s a familiar scenario. You hear about a discovery that could lead to the cure for this disease or that debilitating…

    Read more
  • The 'PA' in LSGPA

    tomb3

    The Life Sciences Greenhouse of Central Pennsylvania’s 42-county service area contains more than 60 institutions of higher …

    Read more